can you abruptly stop glp 1 GLP-1 Survey: 37.5% of People GLP-1s after Just 3 Months Tapering GLP-1 Medications and Why

(56) reported that administering a high dose of RSV (5 g/day) to multiple myeloma patients unexpectedly caused renal damage in five cases, leading to the premature termination of the trial

Theres no guarantee that these small doses wont cause big problems

Oral GLP-1 Approaches Commercial Inflection by 2028 GLP-1 Weight Loss Drug Market Revenue Share, CAGR, and Primary Drivers by Route 2026 Subcutaneous injectable administration commands 81.7% GLP-1 market revenue share in 2026 as the weekly autoinjector format delivers clinical efficacy, dose consistency, and patient convenience superior to daily injectable alternatives

You can use it however many times you like each day